Moreover, in agreement with data previously reported by others [58,59], our results clearly suggested that both the enhancement of oxidative stress and the endothelial dysfunction in this diabetic model were related to increased NADPH oxidase activity, since both alterations were similarly antagonised by the NADPH oxidase inhibitor apocynin. Here, FMO5 is linked to endothelial dysfunction.